Invesaro

Stocks Comparison

Astrana Health vs Genpact: revenue, profit, margins and growth compared

Astrana Health brought in $3.2B of revenue in fiscal 2025, Genpact $5.1B in fiscal 2025. Revenue changed by +56.4% at Astrana Health and +6.6% at Genpact on the year before, so Astrana Health grew faster. Astrana Health kept 0.7% of its revenue as net profit, Genpact 10.9%. Free cash flow was $104.5M at Astrana Health and $734.7M at Genpact.

Side by side, latest fiscal year

ASTHG
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$3.2B$5.1B
Revenue growth+56.4%+6.6%
Net income$22.5M$552.5M
Net margin0.7%10.9%
Free cash flow$104.5M$734.7M
Free cash flow margin3.3%14.5%
Earnings per share (diluted)$0.46$3.13
Cash$429.5M$853.8M
Debt$1B$1.5B
Price to earnings79.110.6
Market value$1.8B$5.6B
Dividend yieldn/a2.05%
Rank by revenue in sector#274 of 778 · Consumer discretionary#200 of 778 · Consumer discretionary

Over the years

Revenue
ASTH FY2018: $519.9MASTH FY2019: $560.6MASTH FY2020: $687.2MASTH FY2021: $773.9MASTH FY2022: $1.1BASTH FY2023: $1.4BASTH FY2024: $2BASTH FY2025: $3.2BG FY2018: $3BG FY2019: $3.5BG FY2020: $3.7BG FY2021: $4BG FY2022: $4.4BG FY2023: $4.5BG FY2024: $4.8BG FY2025: $5.1BFY18FY19FY20FY21FY22FY23FY24FY25
ASTH $3.2BG $5.1B
Net income
ASTH FY2018: $10.8MASTH FY2019: $14.1MASTH FY2020: $37.7MASTH FY2021: $68.9MASTH FY2022: $45.2MASTH FY2023: $60.7MASTH FY2024: $43.1MASTH FY2025: $22.5MG FY2018: $282MG FY2019: $304.9MG FY2020: $308.3MG FY2021: $369.4MG FY2022: $353.4MG FY2023: $631.3MG FY2024: $513.7MG FY2025: $552.5MFY18FY19FY20FY21FY22FY23FY24FY25
ASTH $22.5MG $552.5M
Net margin
ASTH FY2018: 2.1%ASTH FY2019: 2.5%ASTH FY2020: 5.5%ASTH FY2021: 8.9%ASTH FY2022: 3.9%ASTH FY2023: 4.4%ASTH FY2024: 2.1%ASTH FY2025: 0.7%G FY2018: 9.4%G FY2019: 8.7%G FY2020: 8.3%G FY2021: 9.2%G FY2022: 8.1%G FY2023: 14.1%G FY2024: 10.8%G FY2025: 10.9%FY18FY19FY20FY21FY22FY23FY24FY25
ASTH 0.7%G 10.9%
Revenue growth
ASTH FY2019: +7.8%ASTH FY2020: +22.6%ASTH FY2021: +12.6%ASTH FY2022: +47.8%ASTH FY2023: +21.2%ASTH FY2024: +46.7%ASTH FY2025: +56.4%G FY2019: +17.3%G FY2020: +5.4%G FY2021: +8.4%G FY2022: +8.7%G FY2023: +2.4%G FY2024: +6.5%G FY2025: +6.6%FY19FY20FY21FY22FY23FY24FY25
ASTH +56.4%G +6.6%
Free cash flow
ASTH FY2018: $24.3MASTH FY2019: $12.6MASTH FY2020: $45MASTH FY2021: $51.1MASTH FY2022: $59.2MASTH FY2023: $39.7MASTH FY2024: $44.2MASTH FY2025: $104.5MG FY2018: $254.5MG FY2019: $353MG FY2020: $514.1MG FY2021: $640.9MG FY2022: $393.1MG FY2023: $435.4MG FY2024: $532.7MG FY2025: $734.7MFY18FY19FY20FY21FY22FY23FY24FY25
ASTH $104.5MG $734.7M

Fiscal years as each company reports them; the two may end in different months.

Questions about Astrana Health and Genpact

Which is bigger by revenue, Astrana Health or Genpact?

Genpact is bigger by revenue: $5.1B in fiscal 2025, against $3.2B for Astrana Health in fiscal 2025.

Which keeps more of its revenue as profit, Astrana Health or Genpact?

Astrana Health had a net margin of 0.7% in fiscal 2025; Genpact had 10.9% in fiscal 2025.

Which grew revenue faster, Astrana Health or Genpact?

In their latest fiscal years revenue changed by +56.4% at Astrana Health and +6.6% at Genpact.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies